Clinical Trials List
2024-01-01 - 2030-11-30
Phase II/III
Recruiting5
-
Trial Applicant
AbbVie
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/04/01
Investigators and Locations
Co-Principal Investigator
- Wei-Fan Hsu 無
- Cheng-Yuan Peng 無
- 張哲維 無
- 張哲維 無
- Hung-Wei Wang 無
- Hsueh-Chou Lai 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 呂理駿 無
- Chih-Hung Hsu 無
- Chien-Hung Chen 無
- Ying-Chun Shen 無
- 莊建淮 無
- TSUNG-HAO LIU 無
- YU-YUN SHAO 無
- 陳柏邑 無
- 林宗哲 無
- Chiun Hsu 無
- 蘇東弘 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 吳峯旭 無
- YI-JU CHEN 無
- SHAO-CIAO LUO 無
- 呂宜達 無
- 陳家昌 無
- 蘇德晟 無
- CHUNG-HSIN CHANG 無
- 蔡炘儒 無
- TENG-YU LEE 無
- 黃儀倢 無
- Sheng-Shun Yang 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- I-Cheng Lee 無
- 齊振達 無
- Chien-An Liu 無
- Pei-Chang Lee 無
- San-Chi Chen 無
- Yi-Ping Hung 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 顏志傑 無
- Chiu Hung Chiu 無
- 劉奕廷 無
- Hsin-Yu Kuo 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
26 participants
-
Global
660 participants
